antibiot
wide
use
treat
infect
human
howev
impact
antibiot
use
host
cell
understudi
identifi
novel
antivir
effect
commonli
use
aminoglycosid
antibiot
show
mucos
applic
aminoglycosid
increas
host
resist
broad
rang
viral
infect
includ
herp
simplex
virus
influenza
viru
zika
viru
aminoglycosid
treatment
also
reduc
viral
replic
primari
human
cell
antivir
activ
independ
microbiota
aminoglycosid
treatment
protect
germfre
mice
microarray
analysi
uncov
mark
upregul
transcript
interferonstimul
gene
isg
follow
aminoglycosid
applic
isg
induct
mediat
requir
domaincontain
adapterinduc
trif
signal
adaptor
interferon
regulatori
factor
transcript
factor
promot
isg
express
dendrit
cell
uniqu
express
recruit
vagin
mucosa
upon
aminoglycosid
treatment
requir
isg
induct
result
highlight
unexpect
abil
aminoglycosid
antibiot
confer
broad
antivir
resist
vivo
antibiot
wide
use
treat
infect
human
howev
impact
antibiot
use
host
cell
understudi
identifi
novel
antivir
effect
commonli
use
aminoglycosid
antibiot
show
mucos
applic
aminoglycosid
increas
host
resist
broad
rang
viral
infect
includ
herp
simplex
virus
influenza
viru
zika
viru
aminoglycosid
treatment
also
reduc
viral
replic
primari
human
cell
antivir
activ
independ
microbiota
aminoglycosid
treatment
protect
germfre
mice
microarray
analysi
uncov
mark
upregul
transcript
interferonstimul
gene
isg
follow
aminoglycosid
applic
isg
induct
mediat
requir
domaincontain
adapterinduc
trif
signal
adaptor
interferon
regulatori
factor
transcript
factor
promot
isg
express
dendrit
cell
uniqu
express
recruit
vagin
mucosa
upon
aminoglycosid
treatment
requir
isg
induct
result
highlight
unexpect
abil
aminoglycosid
antibiot
confer
broad
antivir
resist
vivo
antibiot
compris
larg
complex
group
compound
typic
secret
bacteria
target
prokaryot
antibiot
revolution
medicin
sinc
discoveri
howev
overus
misus
antibiot
led
emerg
resist
bacteria
human
livestock
current
medicin
face
dire
threat
antibiot
resist
bacteria
rampant
mani
hospit
around
world
addit
microbicid
activ
antibiot
also
directli
affect
mammalian
cell
varieti
way
antibiot
report
directli
inhibit
eukaryot
translat
inhibit
mitochondri
function
induc
chang
mammalian
metabol
pathway
critic
need
better
understand
host
effect
commonli
use
antibiot
found
topic
deliveri
aminoglycosid
antibiot
mucosa
induc
signific
alter
host
gene
express
induc
increas
express
antivir
interferonstimul
gene
isg
aminoglycosidemedi
isg
induct
result
signific
protect
genit
infect
significantli
reduc
zika
viru
replic
aminoglycosidemedi
antivir
protect
independ
host
microbiota
intravagin
aminoglycosid
treatment
protect
germfre
mice
form
infect
protect
mechan
oper
vagin
mucosa
nasal
mucosa
intranas
aminoglycosid
treatment
increas
isg
express
lung
aminoglycosid
pretreat
host
increas
surviv
highli
virul
influenza
viru
infect
isg
express
depend
downstream
signal
pathway
robust
recruit
dendrit
cell
vagin
mucosa
result
reveal
unexpect
induct
antivir
state
commonli
use
aminoglycosid
antibiot
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
pretreat
mice
display
littl
diseas
patholog
compar
control
mice
fig
determin
antibiot
cocktail
requir
protect
hsv
infect
treat
mice
singli
antibiot
compar
diseas
progress
mice
receiv
full
antibiot
cocktail
exclud
metronidazol
present
low
quantiti
cocktail
four
antibiot
test
neomycin
alon
recapitul
host
protect
observ
full
antibiot
cocktail
fig
neomycintr
mice
significantli
lower
vagin
viral
titer
compar
singl
antibiotictr
mice
ident
treat
full
antibiot
cocktail
fig
thu
neomycin
antivir
ingredi
antibiot
cocktail
variabl
protect
data
shown
neomycin
treatment
infect
result
lower
viral
titer
fig
highli
reduc
diseas
outcom
fig
data
indic
vagin
applic
neomycin
shortli
exposur
reduc
infect
diseas
manner
independ
commens
bacteria
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
elucid
mechan
underli
neomycinmedi
host
resist
analyz
vagin
gene
transcript
neomycintr
mice
prior
infect
identifi
hundr
significantli
upregul
gene
fig
supplementari
tabl
gene
significantli
downregul
express
use
ingenu
pathway
analysi
found
gene
type
interferon
ifn
pathway
heavili
enrich
fig
upregul
gene
fall
within
pathway
independ
confirm
upregul
subset
ifnstimulatedgen
isg
use
rtqpcr
fig
isg
express
also
increas
germfre
mice
upon
neomycin
treatment
supplementari
fig
neomycininduc
isg
express
rapid
singl
treatment
suffici
significantli
increas
isg
express
fold
though
level
observ
week
treatment
fold
supplementari
fig
neomycinmedi
isg
induct
also
dosedepend
increas
amount
neomycin
correspondingli
increas
isg
express
supplementari
fig
signific
isg
induct
maintain
day
neomycin
treatment
partial
lost
week
post
neomycin
treatment
gene
still
significantli
upregul
supplementari
fig
final
neomycinmedi
isg
induct
restrict
site
applic
observ
upregul
isg
express
lung
neomycintr
mice
supplementari
fig
neomycin
member
larg
divers
group
aminoglycosid
mani
commonli
use
treat
bacteri
infect
determin
isg
induct
common
across
aminoglycosid
famili
treat
mice
panel
structur
divers
aminoglycosid
day
five
seven
aminoglycosid
test
significantli
increas
isg
express
upon
applic
vagin
mucosa
fig
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
two
noninduc
streptomycin
contain
streptamin
core
distinct
aminoglycosid
amikacin
kanamycin
homolog
contain
addit
lhaba
side
chain
thu
major
aminoglycosid
test
induc
isg
express
upon
applic
vagin
mucosa
sinc
aminoglycosid
mediat
antibiot
activ
bind
ribosom
rna
test
isginduct
observ
nonaminoglycosid
ribosomaltarget
antibiot
mice
treat
intravagin
tetracyclin
chloramphenicol
compound
inhibit
bacteri
protein
synthesi
bind
ribosom
subunit
supplementari
fig
b
compar
neomycin
neither
compound
induc
high
level
isg
suggest
isg
induct
common
properti
antibiot
target
ribosom
previou
studi
report
increas
mitochondri
dysfunct
loss
mitochondria
mammalian
cell
upon
treatment
multipl
class
antibiot
observ
reduct
total
mitochondri
dna
neomycintr
vagin
tissu
supplementari
fig
determin
link
isg
express
antivir
protect
compar
abil
isginduc
nonisg
induc
aminoglycosid
protect
mice
infect
select
two
isginduc
aminoglycosid
kasugamycin
sisomicin
well
two
nonisg
induc
aminoglycosid
amikacin
streptomycin
mice
treat
nonisg
induc
protect
infect
vagin
viral
titer
diseas
score
equival
pbstreat
control
mice
fig
f
kasugamycin
sisomicin
treatment
howev
result
signific
reduct
vagin
viral
titer
diseas
score
display
equival
level
antivir
protect
compar
neomycin
fig
f
data
indic
isg
induct
aminoglycosid
correspond
abil
protect
mice
viral
challeng
aminoglycosid
induc
antivir
protect
rna
dna
virus
across
multipl
mucos
surfac
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
next
examin
aminoglycosidemedi
induct
antivir
immun
specif
vagin
tract
similar
protect
could
observ
mucos
surfac
respiratori
tract
singl
intranas
dose
neomycin
suffic
significantli
upregul
isg
express
lung
fig
determin
isg
induct
result
host
antivir
resist
test
neomycinmedi
protect
function
relev
mous
model
influenza
infect
mani
inbr
mous
strain
includ
lack
ref
encod
myxoviru
resist
protein
like
gtpase
block
primari
transcript
influenza
bind
viral
nucleoprotein
isg
induc
neomycin
treatment
fig
express
confer
resist
influenza
viru
mice
mice
lack
strain
innat
resist
influenza
abrog
reli
adapt
immun
previous
show
oral
neomycin
treatment
render
defici
mice
suscept
influenza
diseas
deplet
gut
commens
bacteria
normal
support
function
dendrit
cell
prime
cell
otherwis
lethal
dose
mice
protect
fig
result
demonstr
mucos
applic
singl
dose
neomycin
result
substanti
protect
highli
virul
influenza
viru
infect
also
test
abil
aminoglycosid
protect
anoth
rna
viru
infect
zika
viru
zikv
zikv
replic
vagina
wildtyp
mice
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
control
type
ifn
secret
ifnar
signal
given
abil
aminoglycosid
induc
isg
examin
aminoglycosidetr
host
protect
zikv
infect
found
kasugamycin
neomycin
treatment
result
significantli
lower
level
zikv
rna
vagin
mucosa
earli
infect
fig
notabl
vagin
zikv
titer
neomycintr
mice
eventu
reach
level
observ
pbstreat
control
zikv
replic
kasugamycintr
mice
remain
significantli
lower
larg
proport
mice
group
fig
extend
find
human
cell
treat
primari
peripher
blood
monocyt
knockout
host
show
rel
lower
level
isg
induct
supplementari
fig
infect
neomycintr
mav
knockout
host
result
reduc
protect
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
supplementari
fig
c
contrast
neomycintreat
sting
knockout
mice
result
robust
antivir
protect
significantli
suppress
viral
replic
littl
diseas
patholog
supplementari
fig
f
result
indic
cytosol
dna
sensor
signal
pathway
dispens
isg
induct
neomycin
rna
sensor
signal
pathway
play
partial
role
aminoglycosidemedi
isg
induct
mice
compar
pbstreat
control
fig
lack
isg
induct
result
lack
protect
infect
fig
induct
isg
via
often
requir
signal
type
ifn
receptor
ifnar
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
ifnindepend
isg
induct
also
report
observ
increas
induct
isg
express
upon
neomycin
treatment
mice
suggest
ifnar
signal
dispens
supplementari
fig
howev
sinc
basal
isg
express
much
lower
mice
compar
wt
neomycin
treatment
increas
gene
express
untreat
wt
mice
thu
neomycin
treatment
accompani
signific
antivir
protect
supplementari
fig
c
collect
result
suggest
neomycin
induc
isg
express
via
activ
signal
pathway
confer
protect
sinc
dc
requir
isg
induct
neomycin
monocytederiv
classic
dc
recruit
vagin
mucosa
wonder
express
could
use
identifi
specif
dc
subset
involv
well
known
express
select
ref
examin
express
across
dc
subset
use
rna
sequenc
dataset
deposit
immunolog
genom
project
confirm
singl
cdc
subset
high
level
express
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
dc
thymu
spleen
supplementari
fig
nonlymphoid
tissu
cell
character
dc
subset
express
high
level
ref
recent
studi
identifi
defin
cell
surfac
marker
subset
thu
measur
recruit
dc
vagin
mucosa
neomycin
treatment
result
signific
recruit
ablat
upon
treatment
pertussi
toxin
fig
b
determin
dc
subtyp
respons
isg
induct
aminoglycosid
deplet
mice
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
aminoglycosid
act
bind
bacteri
ribosom
rna
also
bind
mitochondri
mammalian
ribosom
rna
data
show
aminoglycosid
induct
isg
requir
sensor
dsrna
thu
test
aminoglycosid
induc
isg
express
render
host
rna
visibl
neighbor
dc
test
first
treat
splenocyt
kasugamycin
wash
cell
multipl
time
remov
extracellular
aminoglycosid
next
incub
kasugamycintr
cell
splenic
dc
includ
dc
wt
knockout
mice
measur
dcspecif
isg
express
incub
kasugamycintr
splenocyt
suffici
increas
isg
express
wt
dc
supplementari
fig
data
led
us
hypothes
aminoglycosid
may
bind
dsrna
render
potent
activ
test
treat
splenocyt
combin
aminoglycosid
dsrna
poli
c
found
ratio
poli
c
kasugamycin
significantli
induc
isg
express
greater
level
either
compound
alon
supplementari
fig
enhanc
depend
trif
signal
supplementari
fig
collect
data
indic
high
molar
ratio
kasugamicin
synerg
dsrna
stimul
dc
support
hypothesi
incub
dc
kasugamycintr
splenocyt
suffici
induc
isg
express
albeit
lower
level
direct
aminoglycosid
treatment
supplementari
fig
known
crosspresent
antigen
associ
dead
cell
conceiv
vagin
mucosa
phagocytosi
aminoglycosidecontain
epitheli
cell
result
activ
due
accumul
aminoglycosidebound
rna
endosom
specif
rna
bound
aminoglycosid
trigger
remain
unknown
interact
aminoglycosid
mitochondri
ribosom
rna
close
relat
bacteri
ribosom
rna
well
character
aminoglycosid
also
found
bind
mitochondri
ribosom
rna
multipl
site
possibl
mitochondri
rrnabound
aminoglycosid
might
activ
dc
endosom
result
show
aminoglycosid
poli
c
synerg
induc
increas
isg
express
supplementari
fig
futur
studi
need
identifi
manner
aminoglycosidebound
rna
stimul
result
demonstr
surpris
broad
antivir
effect
aminoglycosid
famili
antibiot
appli
mucos
surfac
howev
advoc
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
use
compound
antivir
aminoglycosid
applic
expect
caus
local
dysbiosi
commens
bacteri
commun
understand
precis
mechan
aminoglycosid
induc
stimul
use
futur
design
broadact
antivir
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mice
charl
river
laboratori
cg
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
scruff
five
day
depo
treatment
mice
vagin
swab
calcium
algin
swab
puritan
main
remov
vagin
mucu
swab
wet
steril
pb
blot
steril
paper
get
rid
excess
liquid
use
ten
microlit
antibiot
pb
deliv
vagin
caviti
use
pipett
tip
day
daili
antibiot
treatment
mice
infect
intravagin
x
x
pfu
pfu
intranas
treatment
mice
anesthet
inject
mixtur
ketamin
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
xylazin
intraperiton
antibiot
administ
dropwis
nasal
caviti
use
pipet
tip
antibiot
obtain
sigmaaldrich
darmstadt
germani
flowjo
softwar
tree
star
use
visual
analyz
cytometri
data
cell
popul
analyz
shown
gate
scheme
supplementari
fig
statist
gene
express
data
analyz
use
unpair
ttest
assum
unequ
standard
deviat
correct
multipl
comparison
use
holmsidak
correct
unless
otherwis
specifi
graph
depict
diseas
score
analyz
use
anova
holmsidak
correct
multipl
comparison
graph
depict
viral
titer
across
time
cours
infect
analyz
use
anova
correct
multipl
comparison
fisher
lsd
unless
otherwis
specifi
surviv
curv
analyz
use
logrank
mantelcox
test
p
valu
report
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
figur
found
supplementari
convent
ad
gh
germfre
e
f
mice
treat
subcutan
provera
five
day
treatment
inocul
intravagin
antibiot
cocktail
b
singli
indic
antibiot
ch
daili
day
n
mice
per
group
week
treatment
mice
infect
intravagin
therapeut
neomycin
treatment
depotr
mice
infect
treat
neomycin
pb
infect
g
h
diseas
score
monitor
daili
c
e
g
vagin
wash
collect
first
three
day
b
f
h
error
bar
repres
sem
signific
calcul
use
anova
exact
p
valu
report
tabl
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
infect
e
f
diseas
score
monitor
e
vagin
viral
titer
measur
f
error
bar
repres
sem
statist
signific
calcul
use
anova
exact
p
valu
comparison
report
tabl
tabl
depotr
wildtyp
knockout
mice
indic
genotyp
treat
neomycin
daili
day
vagin
gene
express
measur
g
independ
experi
mice
infect
diseas
score
b
e
h
vagin
viral
titer
measur
c
f
mice
use
wild
type
control
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
mice
b
c
mice
use
wildtyp
control
remain
di
error
bar
repres
sem
signific
calcul
use
anova
b
e
h
unpair
ttest
correct
multipl
comparison
exact
p
valu
comparison
report
tabl
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
diphtheria
toxin
deplet
cell
treat
intravagin
neomycin
two
day
vagin
gene
express
measur
via
qpcr
c
exact
p
valu
comparison
report
tabl
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
b
mice
treat
subcutan
depoprovera
inocul
intravagin
indic
aminoglycosid
pb
daili
week
week
treatment
mice
infect
viral
titer
vagina
measur
indic
time
point
ac
viral
titer
dorsal
root
ganglion
measur
day
post
infect
error
bar
repres
sem
signi
canc
calcul
use
unpair
ttest
exact
p
valu
report
tabl
depotr
outbr
germfre
swisswebst
mice
treat
neomycin
pb
daili
day
vagin
gene
express
analyz
error
bar
repres
sem
statist
signi
canc
determin
use
oneway
anova
repres
p
valu
exact
p
valu
report
tabl
mice
treat
subcutan
depoprovera
inocul
intravagin
neomycin
mg
pb
day
n
mice
per
group
hour
later
vagin
gene
express
quanti
ed
depotr
mice
innocul
intravagin
neomycin
pb
daili
day
mice
sacri
ced
day
last
neomycin
treatment
shown
b
vagin
gene
express
analyz
time
point
c
depotr
mice
inncolu
neomycin
daili
day
vagin
lung
isg
express
analyz
mice
day
post
neomycin
treatment
error
bar
repres
sem
signi
canc
calcul
use
unpair
ttest
correct
multipl
comparison
exact
p
valu
report
tabl
mice
treat
subcutan
depoprovera
day
treatment
inocul
intravagin
indic
antibiot
day
mice
per
group
vagin
gene
express
b
mitochondri
dna
abund
c
analyz
via
qpcr
signi
canc
calcul
use
unpair
ttest
correct
multipl
comparison
indic
p
valu
exact
p
valu
comparison
report
tabl
etohwat
neomycin
tabl
depotr
mice
treat
intravagin
neomcyin
day
infect
diseas
score
monitor
vagin
viral
titer
measur
b
error
bar
repres
sem
statist
signi
canc
calcul
use
anova
b
speci
c
p
valu
report
tabl
type
ifn
receptor
knockout
mice
accompani
wt
control
treat
subcutan
depoprovera
treat
intravagin
neomycin
pb
daili
day
vagin
gene
express
measur
via
qpcr
independ
experi
neomycintr
mice
pbstreat
control
also
infect
diseas
score
monitor
daili
b
vagin
viral
titer
measur
c
error
bar
repres
sem
signi
canc
calcul
use
either
unpair
ttest
anova
b
c
correct
multipl
comparison
exact
p
valu
comparison
report
tabl
mice
treat
subcutan
depoprovera
inocul
intravagin
pb
neomycin
one
week
vagin
tissu
neomycintr
pb
control
mice
xed
embed
stain
hematoxylin
eosin
imag
magni
ed
splenocyt
treat
kasugamycin
hour
dead
cell
quanti
ed
use
xabl
livedead
stain
frequenc
total
leukocyt
c
total
cell
independ
experi
kasugamycintr
splenocyt
deplet
dc
isg
express
quanti
ed
e
error
bar
repres
sem
exact
p
valu
report
tabl
splenocyt
treat
kasugamycin
hour
wash
thoroughli
stain
cell
trace
violet
incub
dc
isol
wt
splenocyt
hour
incub
dc
cell
trace
violet
dim
neg
cell
sort
rna
extract
isg
express
quanti
ed
error
bar
repres
sem
speci
c
p
valu
detail
tabl
